XML 20 R9.htm IDEA: XBRL DOCUMENT
v3.21.2

CONDENSED STATEMENTS OF CASH FLOWS (Parenthetical) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended
--- | --- | ---
Jun. 30, 2021 | Sep. 30, 2021 | Sep. 30, 2020
Stock issuance expenses | $ 800 | $ 776 | $ 634
Series D Convertible Preferred Stock |  |  |
Discount of issuance of common stock, preferred stock and warrants for clinical trial funding commitment |  | $ 0 | $ 488

X
- Definition Discount Of Issuance Of Common Stock, Preferred Stock And Warrants For Clinical Trial Funding Commitment + References No definition available. + Details
Name: | crdf_DiscountOfIssuanceOfCommonStockPreferredStockAndWarrantsForClinicalTrialFundingCommitment
Namespace Prefix: | crdf_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash outflow for cost incurred directly with the issuance of an equity security. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585 + Details
Name: | us-gaap_PaymentsOfStockIssuanceCosts
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=crdf_SeriesDConvertiblePreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |